C2N Diagnostics, a leader in advanced brain health diagnostics, announced the presentation of two research studies at the AD/PD 2023 International Conference on Alzheimer’s...
Cognito Therapeutics, announced neuroimaging results evaluating the effects of the company’s non-invasive neuromodulation medical device, which delivers proprietary gamma frequency light and sound stimulation in...
